— Know what they know.
Not Investment Advice

OCGN NASDAQ

Ocugen, Inc.
1W: +0.0% 1M: -22.7% 3M: -31.5% YTD: -26.1% 1Y: -39.3% 3Y: +150.8% 5Y: -86.5%
$1.02
+0.02 (+2.00%)
 
Weekly Expected Move ±12.1%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $345.9M mcap · 316M float · 2.16% daily turnover · Short 63% of daily vol

Income Trends

Revenue
$4M +8.8% ▲
5Y CAGR: +152.5%
Gross Profit
$2M -3.0% ▼
Operating Income
-$63M -14.9% ▼
Net Income
-$68M -25.5% ▼
EPS (Diluted)
$-0.23 -15.0% ▼
EBITDA
-$61M -14.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$2M$6M$4M$4M
YoY Growth-100.0%+0.0%+142.6%-32.8%+8.8%
Cost of Revenue$0$0$704K$2M$2M
Gross Profit$0$2M$5M$2M$2M
Gross Margin—100.0%88.3%51.5%45.9%
R&D Expenses$35M$56M$40M$32M$40M
SG&A Expenses$23M$35M$32M$27M$28M
Operating Expenses$58M$92M$71M$57M$65M
Operating Income-$58M-$89M-$66M-$55M-$63M
Operating Margin—-3580.0%-1085.7%-1350.4%-1425.7%
Interest Expense$79K$0$0$0$5M
Income Before Tax-$58M-$87M-$63M-$54M-$68M
Tax Expense-$52K$0$0$0$0
Net Income-$58M-$87M-$63M-$54M-$68M
Net Margin—-3488.9%-1045.0%-1333.0%-1537.4%
EPS (Diluted)$-0.30$-0.40$-0.26$-0.20$-0.23
EBITDA-$58M-$89M-$65M-$53M-$61M
Shares Outstanding195M215M244M271M300M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms